OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19: Discovery, diagnostics and drug development
Tarik Asselah, David Durantel, Éric Pasmant, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 1, pp. 168-184
Open Access | Times Cited: 405

Showing 1-25 of 405 citing articles:

Pharmacological activation of STING blocks SARS-CoV-2 infection
Minghua Li, Max Ferretti, Baoling Ying, et al.
Science Immunology (2021) Vol. 6, Iss. 59
Open Access | Times Cited: 159

Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions
Ashwin Dhakal, Cole McKay, John J. Tanner, et al.
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 143

Recent advances in regenerative biomaterials
Dinglingge Cao, Jiandong Ding
Regenerative Biomaterials (2022) Vol. 9
Open Access | Times Cited: 130

Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages
Jiadi Lv, Zhenfeng Wang, Yajin Qu, et al.
Cell Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 127

SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4
Fanny Onodi, Lucie Bonnet‐Madin, Laurent Meertens, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 4
Open Access | Times Cited: 124

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113

Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment
Zhaoyan Zhao, Yuchen Xiao, Lingqing Xu, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 18, pp. 20995-21006
Open Access | Times Cited: 105

Antiviral Activity Exerted by Natural Products against Human Viruses
Maria Musarra‐Pizzo, Rosamaria Pennisi, Ichrak Ben Amor, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 828-828
Open Access | Times Cited: 100

Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
Yuwen Zhou, Yao Xie, Liansha Tang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 99

The Evolution of Single-Cell RNA Sequencing Technology and Application: Progress and Perspectives
Shuo Wang, Si-Tong Sun, Xinyue Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2943-2943
Open Access | Times Cited: 57

The Potential Applications and Challenges of ChatGPT in the Medical Field
Yonglin Mu, Dawei He
International Journal of General Medicine (2024) Vol. Volume 17, pp. 817-826
Open Access | Times Cited: 15

SARS-CoV-2 immunity in animal models
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 13

A comprehensive review on pyrimidine analogs-versatile scaffold with medicinal and biological potential
N. Jeelan Basha, Naganna M. Goudgaon
Journal of Molecular Structure (2021) Vol. 1246, pp. 131168-131168
Closed Access | Times Cited: 87

Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer
Liyan Yang, Zhonglei Wang
Biomedicines (2021) Vol. 9, Iss. 6, pp. 689-689
Open Access | Times Cited: 84

Evaluation and Comparison of Serological Methods for COVID-19 Diagnosis
Fanwu Gong, Hua-Xing Wei, Qiangsheng Li, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 83

SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants
John Charles Rotondo, Fernanda Martini, Martina Maritati, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1687-1687
Open Access | Times Cited: 74

Cytokine Signature Associated With Disease Severity in COVID-19
Jing Guo, Shuting Wang, Xia He, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 72

Antimicrobial Properties of Food Nanopackaging: A New Focus on Foodborne Pathogens
Seyed Amir Ali Anvar, Hamed Ahari, Maryam Ataee
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 70

Cellular Immune Response to COVID-19 and Potential Immune Modulators
Xi Zhou, Qing Ye
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69

Liver injury in the era of COVID-19
Halina Cichoż‐Lach, Agata Michalak
World Journal of Gastroenterology (2021) Vol. 27, Iss. 5, pp. 377-390
Open Access | Times Cited: 64

SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants
Fengming Sun, Xiuhua Wang, Shun Tan, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 63

Nanotechnology‐Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID‐19 Vaccines
Chiara Rinoldi, Seyed Shahrooz Zargarian, Paweł Nakielski, et al.
Small Methods (2021) Vol. 5, Iss. 9
Open Access | Times Cited: 55

Page 1 - Next Page

Scroll to top